Added to YB: 2024-10-24
Pitch date: 2024-10-24
TMDX [bullish]
TransMedics Group, Inc.
+1.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$123.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
TRANSMEDICS GROUP INC TMDX
A summary for this pitch has not been created yet.
Read full article (0 min)